Study for people with stage IV lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study focuses on improving outcomes for people with stage IV non-small cell lung cancer by gathering health, treatment, and lifestyle information. It may help researchers understand what supports survival and care planning, especially for people who are current smokers or recent quitters.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV non-small cell lung cancer that has been confirmed by pathology (or doctors strongly expect it is stage IV)
- You can speak English
- You are able and willing to share medical records, insurance/billing information, samples, and answer questionnaires (by phone, online, or in person)
- If you are in the “smoking” part of the study: you smoke at least one cigarette most days, or you quit within the last 3 months (and your household members must also smoke)
- You can sign consent and do interviews/samples; hearing or vision problems that stop this mean you may not qualify
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes medical information (and sometimes tissue samples) to help personalize treatment plans for advanced non-small-cell lung cancer using immunotherapy. It may help researchers find which people benefit most and how treatment can be better matched to each patient.
This study tests a new resource to help smokers who have or may have lung cancer quit smoking. The goal is to see if this resource makes it easier to stop smoking.
This trial looks at information and tissue from people with stage I to stage IIIA non-small cell lung cancer (NSCLC) who have surgery, sometimes with chemotherapy before surgery. Researchers want to understand why cancers come back (resistance) and how to better target treatments later.
This observational study follows adults with newly diagnosed non-small cell lung cancer to understand what treatments are used and how patients are doing. It may help doctors better understand how care decisions affect outcomes, and it does not require the study to give an experimental treatment.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
Hear when a new Cigarette Smoker trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.